Related Experiment Videos
[Studies on the bioavailability of sustained-release indomethacin capsules]
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|May 1, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacokinetics of 2-hydroxyflutamide, a major metabolite of flutamide, in normal and CCl4-poisoned rats.
Zhongguo yao li xue bao = Acta pharmacologica Sinica·2000
Flutamide suppressed prostate hypertrophy in rats and mice.
Zhongguo yao li xue bao = Acta pharmacologica Sinica·2000
[The protective effects of curcumin loaded mesoporous silica nanoparticles on rat cardiomyocytes].
Yao xue xue bao = Acta pharmaceutica Sinica·2018
[Identification of water buffalo horn and its adulterants using COI barcode].
Yao xue xue bao = Acta pharmaceutica Sinica·2018
[Construction of the brain-targeting drug carrier through imprinting of nicotinic acetylcholine receptor α7].
Yao xue xue bao = Acta pharmaceutica Sinica·2018
[Application of magnetic iron oxide nanoparticles in magnetic resonance / photothermal dual-modal imaging].
Yao xue xue bao = Acta pharmaceutica Sinica·2018
[Endocytosis pathway and intracellular distribution of heparosan].
Yao xue xue bao = Acta pharmaceutica Sinica·2018
[On-line detection of concentration process of Ganmaoling granules by near infrared spectroscopy combined with automatic control system].
Yao xue xue bao = Acta pharmaceutica Sinica·2018
Medicaid payment policies for methadone maintenance treatment for opioid use disorder, 2020-2025.
Health affairs scholar·2026
Advanced drug delivery systems for topical treatment of common skin diseases: a decade in review.
International journal of pharmaceutics·2026
Radiolabeled drug-delivery and controlled-release nanocarriers for arthritis: Clinical evidence, kinetic modeling, radiation-safety challenges, and precision nanotheranostics.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD).
Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Propofol for depression: mechanisms and therapeutic potential.
Frontiers in physiology·2026